Each grid is 100 men and each icon is one man's answer. The answers come from men treated in the PACE-B trial with five-fraction stereotactic radiotherapy (SBRT) or conventional radiotherapy (CRT), asked the same questions before treatment and at 1, 2 and 5 years.
Data from Cooper et al., European Urology 2026;90:321–327 (open access).
An independent visual summary of patient-reported outcomes published from the PACE-B trial, prepared by Dr Sian Cooper, a co-author. This is not an official PACE trial website.
Before treatment, 77 in 100 men in PACE-B said they rarely or never leaked urine. Five years later, 64 in 100 men who had SBRT and 69 in 100 who had conventional radiotherapy said the same. Five years after SBRT, 17 in 100 men leaked about once a day or more (11 in 100 before treatment), and 91 in 100 used no pads (98 in 100 before treatment).
Five years after SBRT, 95 in 100 men said their bowel habits were no problem, a very small problem or a small problem, compared with 98 in 100 before treatment. 2 in 100 said bloody stools were a moderate or big problem, and 2 in 100 said the same about losing control of their stools. No men reported either as a moderate or big problem before treatment.
Before treatment, 35 in 100 men in the SBRT group had erections firm enough for intercourse and 23 in 100 had no erections at all. Five years after SBRT, 17 in 100 had erections firm enough for intercourse and 39 in 100 had none. The figures five years after conventional radiotherapy were similar: 19 in 100 and 38 in 100.
The grids show men's answers before treatment and then 1, 2 and 5 years afterwards, so you can see how each side effect changed over time. Open a question above and press Play to watch the change.
SBRT gives the radiotherapy in 5 treatments. Conventional radiotherapy in PACE-B was given in 20 or 39 treatments. At five years, the differences between the two were not statistically significant for any of the outcomes shown here.
The main options for prostate cancer that has not spread are active surveillance (regular monitoring), surgery to remove the prostate (radical prostatectomy) and radiotherapy. Each has different side effects. This page shows what men reported after radiotherapy. Your own doctors and nurses can tell you which options are suitable for you.
This page is information, not medical advice. Please talk to your own team about your treatment.
PACE-B randomised 874 men with low or intermediate-risk prostate cancer to SBRT (36.25 Gy in 5 fractions) or CRT (78 Gy in 39 or 62 Gy in 20 fractions). Men completed the EPIC-26 questionnaire before treatment and at 1, 2 and 5 years. Fewer men answered at later time points, so each grid shows its own number of men answering.
Each grid rounds the share of men giving each answer to whole numbers out of 100. Icons fill column by column; erection quality fills from the bottom of each column. Differences between SBRT and CRT were not statistically significant at five years for any of these outcomes.
Icon arrays show proportions as countable people, which tends to be easier to read than percentages alone. The format follows the one used by the TrueNTH collaboration. The original figures were drawn in R with the RiskCom waffles() function by Joshua Bridge.